NCT00113555View on ClinicalTrials.gov

Adjustable Continence Therapy (ACT) Device for the Treatment of Female Stress Urinary Incontinence

NACompletedINTERVENTIONAL
Enrollment

221

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

July 31, 2008

Study Completion Date

November 30, 2010

Conditions
Urinary Incontinence
Interventions
DEVICE

ACT (Adjustable Continence Therapy)

surgically implanted device

Trial Locations (7)

30322

Emory University School of Medicine, Atlanta

55441

Metro Urology, Plymouth

64123

Kansas City Urology Care, Kansas City

90027

Kaiser Permanente, Los Angeles

01805

Lahey Clinic, Burlington

V8T5GI

Can-Med Clinical Research Inc., Victoria

J1H5N4

CHUS-Fleurimont, Fleurimont

Sponsors

Lead Sponsor

Uromedica
All Listed Sponsors
lead

Uromedica

INDUSTRY

NCT00113555 - Adjustable Continence Therapy (ACT) Device for the Treatment of Female Stress Urinary Incontinence | Biotech Hunter | Biotech Hunter